ARTIVION, INC.

By person

33 insiders · 344 transactions

26.2×

J. Patrick Mackin holds 26.2 times base salary in stock. $21.91M of shares against $835.15K in salary for 2025.

Salary from the company's own proxy. The shares are what J. Patrick Mackin last reported holding, valued at $24.97, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mackin James P

President & CEO

$117.36K (1)

$29.72M (41)

−$29.60M

877,275

1.80%

$21.91M

+139.0%

Holloway Jean F

SVP, General Counsel

—

$7.82M (54) scheduled

−$7.82M

184,118

0.3776%

$4.60M

+368.8%

Stanton Marshall S.

SVP, Clinical & MD Affair

—

$6.07M (35) scheduled

−$6.07M

60,097

0.1233%

$1.50M

+868.4%

LEE DAVID ASHLEY

Executive VP, COO & CFO

—

$4.99M (14) scheduled

−$4.99M

394,217

0.8085%

$9.84M

+29.9%

Davis John E

Chief Commercial Officer

$176.86K (2)

$4.48M (37) scheduled

−$4.31M

230,794

0.4734%

$5.76M

+643.8%

Horton Amy

VP, Chief Accounting Officer

—

$4.23M (43) scheduled

−$4.23M

139,088

0.2853%

$3.47M

+82.8%

GREEN ANDREW M

SVP, Regulatory and Quality

—

$1.88M (16) scheduled

−$1.88M

40,160

0.0824%

$1.00M

+49.9%

McCall Ronald D

Director

—

$1.32M (15)

−$1.32M

137,768

0.2826%

$3.44M

−18.6%

Berry Lance A

EVP, COO, CFO & Treasurer

—

$1.01M (7)

−$1.01M

210,112

0.4309%

$5.25M

—

RONALD C ELKINS

Director

—

$1.01M (12)

−$1.01M

64,843

0.1330%

$1.62M

−36.8%

Maier Dennis B

SVP, Operations

—

$813.80K (16)

−$813.80K

34,724

0.0712%

$867.06K

+239.8%

Capps Scott B

VP, Clinical Research

—

$812.46K (5) scheduled

−$812.46K

153,203

0.3142%

$3.83M

+54.1%

Getz Matthew A

VP, Human Resources

—

$575.72K (13)

−$575.72K

34,116

0.0700%

$851.88K

+103,282%

Gale David C

VP, Research & Development

—

$392.50K (2) scheduled

−$392.50K

77,135

0.1582%

$1.93M

+11.5%

MORGAN HARVEY

Director

—

$325.43K (3)

−$325.43K

220,802

0.4529%

$5.51M

+6.5%

Maney Rochelle L.

VP, Quality

—

$275.76K (9)

−$275.76K

46,536

0.0954%

$1.16M

+215.7%

Hoff Elizabeth A

Director

—

$189.41K (1)

−$189.41K

34,765

0.0713%

$868.08K

—

Bullock James

Director

$166.27K (1)

—

+$166.27K

76,223

0.1563%

$1.90M

+2,438%

Benson James

Director

—

$45.60K (1)

−$45.60K

54,086

0.1109%

$1.35M

−15.6%

Tyrs Florian

VP, Global Operations

—

$29.52K (3)

−$29.52K

21,558

0.0442%

$538.30K

+49.8%

SEMEDO ANTHONY B.

Director

$313.54K (3)

$316.66K (2)

−$3.11K

46,960

0.0963%

$1.17M

—

BEVEVINO DANIEL J

Director

—

157,637

0.3233%

$3.94M

+67.5%

ACKERMAN THOMAS F

Director

—

157,472

0.3230%

$3.93M

+67.4%

Salveson Jon W

Director

—

137,416

0.2818%

$3.43M

+85.5%

Burbank Jeffrey H

Director

—

61,372

0.1259%

$1.53M

+1,641%

Borgstrom Marna P

Director

—

56,938

0.1168%

$1.42M

—

Matthews William Robert

Senior VP, Operations, Quality

—

39,883

0.0818%

$995.88K

+110.2%

Simpson Michael S

SVP, Regulatory Affairs and QA

—

33,698

0.0691%

$841.44K

+184.9%

Barthold Franz Peter

VP, Research & Development

—

32,516

0.0667%

$811.92K

+369.0%

McDermid James M

SVP, CHRO

—

30,806

0.0632%

$769.23K

+616.1%

Saurini Sherry M

VP, Quality

—

25,084

0.0514%

$626.35K

−4.2%

Bogenschuetz Thomas J

VP, EMEA & General Manager

—

23,451

0.0481%

$585.57K

+76.2%

THOMSON ROBERT C

VP Research & Development

—

13,291

0.0273%

$331.88K

—

By person

Individual transactions

What was left out